Search results
LEO Pharma reports positive data from Phase III plaque psoriasis trial
Clinical Trials Arena via Yahoo Finance· 2 days agoLEO Pharma has announced positive data from the Phase III clinical trial of Enstilar (LEO 90100) in...
IPC Develops Consensus on Generalized Pustular Psoriasis
Medscape· 2 days agoThe IPC's definition and diagnostic criteria for GPP minimized the complexity of clinical...
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
FOX 5 San Diego· 13 hours agoCelltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale ...
Protagonist Reports First Quarter 2024 Financial Results and Provides Corporate Update
Morningstar· 3 days agoEntered into a worldwide license and collaboration agreement for rusfertide with Takeda; Cash runway extended through Q4 2027[1]Enrollment in both Phase 3 ICONIC LEAD and ICONIC TOTAL trials ...
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 3 days agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
5 Best Undervalued Stocks To Buy In May 2024
Forbes· 1 day agoResearching undervalued stocks? We examined stocks to identify the top undervalued stocks in May 2024. Dive into the results here.
VYNE Therapeutics receives FDA approval for trial of VYN202
Clinical Trials Arena via Yahoo Finance· 3 days agoIf the Phase Ia segment is successful, VYNE will advance the drug to Phase Ib trials in individuals...
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
InvestorPlace· 3 days agoInvestors concerned about broader market undulations may want to consider the resilience narrative...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 7 days agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 2 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...